What You Need To Know About Subsys Spray Lawsuit

Subsys spray is a powerful and addictive painkiller for cancer. Taken as an oral spray, it is considered as one of the most potent and dangerous opioids at about 80 – 100 times stronger than morphine. Because it is sprayed underneath the tongue, it gets into the bloodstream faster than traditional methods of delivery. It is used for the treatment of chronic pain.

Insys Therapeutics, the manufacturer of Subsys or Fentanyl Spray is currently under investigation for off-label prescription of fentanyl. Subys is approved by the FDA for breakthrough cancer pain. The drug was allegedly prescribed for conditions which Fentanyl was not approved for. According to reports, it was prescribed for joint pain and post-traumatic stress disorder. The manufacturer of the drug allegedly falsified records so the drug can be taken by non-cancer patients.

Introduced in 2012, the Adverse Events Reporting System of the FDA has listed around 203 deaths with Subsys listed as being the probable cause for triggering an adverse reaction. In the second quarter of 2015 alone, the number of fentanyl related deaths was 52. Insys is now under Federal and state investigations in Oregon, California, Massachusetts, Connecticut, Arizona, and Illinois. To date, the company has already settled a total of $7.2 million in class action suit in Oregon and Arizona.

The website of Williams Kherkher revealed that the sales of Insys increased to more than $90 million in the third quarter of 2015 alone despite the cost of hundreds of overdose deaths, lost loved ones, and ruined lives. The dangers of fentanyl became known to the public after reports of serious side effects and deaths linked to Duragesic pain patch or Fentanyl patches were issued. Overdose of the drug caused respiratory failure, permanent coma, and death. Due to these problems, the patches have been subjected to numerous recalls.

Leave a Reply

Your email address will not be published. Required fields are marked *